Produktname:(6-(Cyclobutylmethoxy)pyrimidin-4-yl)methanamine

IUPAC Name:1-[6-(cyclobutylmethoxy)pyrimidin-4-yl]methanamine

CAS:1439898-15-3
Molekulare Formel:C10H15N3O
Reinheit:97%
Katalognummer:CM504713
Molekulargewicht:193.25

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM504713-1g 1-2 Weeks ŌƈŌ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1439898-15-3
Molekulare Formel:C10H15N3O
Schmelzpunkt:-
SMILES-Code:NCC1=NC=NC(OCC2CCC2)=C1
Dichte:
Katalognummer:CM504713
Molekulargewicht:193.25
Siedepunkt:
Mdl-Nr.:MFCD26096967
Lagerung:

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.
Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.